CompletedNot Applicable

Vascular Access Complications for Therapeutic Apheresis in Nephrology

France60 participantsStarted 2020-06-01

Plain-language summary

The aim of this study is to describe vascular access complications which are used for therapeutic apheresis in Nephrology.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients in nephrology receiveing apheresis treatment by filtration or double filtration Exclusion Criteria: * apheresis treatment for other indications * centrifugation apheresis treatment

What they're measuring

Vascular access Complication (catheter or AVF/AVG thrombosis/infection) rate in therapeutic apheresis among nephrological diseases

Timeframe: june 2020 june 2022

Trial details

NCT IDNCT05894317

SponsorCentral Hospital, Nancy, France

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-06-30

View on ClinicalTrials.gov More Vascular Access Complication trials